Vineet Laboratories Ltd.

49.30 +1.12 ▲2.3%

28 March 2024, 04:01:00 PM
Volume: 2,315

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vineetlabs.co.in
Market Cap 45.45 Cr.
Enterprise Value(EV) 84.96 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.87 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 17.15 Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 35.56 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.39 Calculated using Price: 49.30
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.92 Cr. 9,219,008 Shares
FaceValue 10
About Vineet Laboratories Ltd.
The company is engaged in the business of Drug Intermediates & Bulk Dugs.

Vineet Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Vineet Laboratories Ltd. Performance

1 Day
+2.32%
1 Week
+1.86%
1 Month
-15.48%
3 Month
-29.27%
6 Month
-5.16%
1 Year
+17.10%
2 Year
-10.36%
5 Year
10 Year

Vineet Laboratories Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 0 -2.87 13.18 22.19 3.74
Return on Capital Employed (%) 0 0 -2.87 34.06 23.14 8.69
Return on Assets (%) 0 0 -2.72 3.26 5.49 1.01

Vineet Laboratories Ltd. Balance Sheet

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 0 0 27 33 34 35
Non Curr. Liab. 7 5 8 7
Curr. Liab. 0 0 75 95 75 80
Minority Int.
Equity & Liab. 0 0 0 109 133 116 122
Non Curr. Assets 22 31 28 28
Curr. Assets 0 0 0 86 103 87 94
Misc. Exp. not W/O 0 0
Total Assets 0 0 0 109 133 116 122

Vineet Laboratories Ltd. Profit and Loss

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 243 191 212 171
Other Income 0 0 0 0
Total Income 244 191 212 171
Total Expenditure 0 -235 -178 -205 -161
PBIDT 0 9 13 8 10
Interest -3 -2 -3 -3
Depreciation -2 -2 -2 -2
Taxation -2 -3 -1 -1
Exceptional Items
PAT 0 2 7 1 3
Adjusted EPS 0 2 7 1 3

Vineet Laboratories Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 27 8 -10
Cash Fr. Inv. -8 -4 -7
Cash Fr. Finan. 19 12 0
Net Change 38 16 -16
Cash & Cash Eqvt 38 17 1

Vineet Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 35.96 35.96 35.96 35.96 35.96 38.66 38.66 38.66 37.55
Public 64.04 64.04 64.04 64.04 64.04 61.34 61.34 61.34 62.45
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Vineet Laboratories Ltd. Announcements

Fri, 29 Mar 2024
Closure of Trading Window
The trading window for dealing in the securities of the Company will remain closed from April 1 2024 till 48 hours after the announcement of Standalone Audited Financials Results for the Fourth Quarter and the Financial Year ended on March 31 2024. for all the designated persons their immediate relatives and all the connected persons covered under the code.The Company has ensured freezing of PAN of all the designated persons and their immediate relatives during the period of trading window closure.
Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of the Unaudited Financial Results for the Third Quarter and Nine months ended on December 31 2023.
Mon, 12 Feb 2024
Board Meeting Outcome for Outcome For The Board Meeting Held On Monday February 12 2024 As Required Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
The Board of Directors in its meeting held today i.e. on February 12 2024 has considered and approved the unaudited Financial results of the Company for the Third Quarter and the Nine months ended on December 31 2023

Vineet Laboratories Ltd. Technical Scans

Thu, 28 Mar 2024
Close Below Last Month Low Close Below Last Month Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
Bullish Harami Cross Bullish Harami Cross

Vineet Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Vineet Laboratories Ltd. FAQ's

What is Vineet Laboratories share price?

Can I buy Vineet Laboratories shares now?

What is the Market Cap of Vineet Laboratories?

What are the key metrics to analyse Vineet Laboratories?

What is the 52 Week High and Low of Vineet Laboratories?

What is the trend of Vineet Laboratories share price?